Meihua International explores application of ChatGPT technology to develop online artificial intelligence health consulting services

PR Newswire ·  02/08/2023 20:45

YangzhouFebruary 8, 2023/ PR Newswire /-- Meihua International Medical Technology Co., Ltd. ("MHUA" or "Company") (NASDAQ: MHUA), a reputable manufacturer and supplier of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that the company will seek to explore the application of ChatGPT technology to develop online health consulting services and is actively laying out related device applications and technology platform research and development.

In recent years, companies have been exploring the application of intelligent content and data generation technologies to help accelerate the development of online artificial intelligence health consulting services that often involve unstructured text collection and analysis.

MHUA will seek to work with research centers in this field to conduct in-depth analysis of the possible application and expansion of ChatGPT-related technologies in the company's efforts to develop online artificial intelligence health consulting services.

ChatGPT technology can read and analyze large amounts of text and data, and generate sentences similar to the way humans speak and write, including finding patterns in datasets without tagged examples or clear instructions about what to look for. These technologies are designed to digest content from the entire network, which means that users may receive more relevant and informed answers.

The company believes that ChatGPT technology has great potential to assist in online health counseling, which involves answering questions about basic health care that do not necessarily require in-person consultation. In addition, this technology may help push automated health counseling services to new heights, providing relevant answers so that users do not have to wait to talk to doctors or nurses, which may help reduce waiting time. at the same time, provide informed answers to more basic health-related questions.

Mr. Wang Xin, CEO of the company, commented: "ChatGPT is one of the fastest artificial intelligence tools in history. It is very useful for general research purposes, but it has not been widely used in dealing with complex life science texts and data. We are looking to work with industry experts to try to explore the potential of ChatGPT technology to assist MHUA in its R & D capabilities and its efforts to develop our online health counseling platform, which may help create virtual assistants to provide personalized advice and advice to patients based on their medical history, current symptoms and other relevant factors. "

About Meihua International Medical Technology Co., Ltd.

Meihua International Medical Technology Co., Ltd. (Meihua International Medical Technologies Co., Ltd.) is a well-known manufacturer and supplier of Class I, II and III disposable medical devices in China, with operating subsidiaries in China. The company produces and sells Class I disposable medical supplies, such as eye drops bottles, medicine bottles, artificial anal bags, and identify wristbands, gynecological examination kits, surgical examination kits, operation kits, medical brushes, medical dressings, masks, disposable infusion pumps, electronic pumps, puncture bags and other II and III disposable medical devices, and act as agents for the distribution of disposable medical devices purchased from other manufacturers. The company has passed the international "CE" certification and ISO 13485 system certification, and has registered more than 20 products in FDA (registration number: 3006554788) in the United States. The company has served hospitals, pharmacies, medical institutions and medical equipment companies for more than 30 years, with more than 800 products sold in China and more than 120 products exported to more than 30 countries throughout Europe, North America, South America, Asia, Africa and Oceania. For more information, please visit.

Forward-looking statement

The statements in this press release regarding the Company's future expectations, plans and prospects constitute forward-looking statements as defined by Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements about plans, goals, objectives, strategies, future events, expected results, assumptions and any other factual statements that have not occurred. Any expression that refers to "may", "will", "want", "should", "believe", "expect", "expect", "estimate", "estimate" or similar non-factual words, in particular, the listing of the company on the Nasdaq global market and the completion of the offering shall be regarded as forward-looking statements. Due to various factors, the actual results may differ materially from the historical results or the contents expressed in these forward-looking statements. These factors include, but are not limited to, the company's strategic objectives, the company's future plans, market demand and user acceptance of the company's products or services, technological updates, economic trends, the company's reputation and brand, the impact of industry competition and bidding, relevant policies and regulations, the ups and downs of China's macroeconomic conditions, the international market conditions served by the company, and the related risks and assumptions disclosed in the prospectus. In view of the above and other related reasons, we advise investors not to blindly rely on these forward-looking statements, and we urge investors to visit the SEC website to consult the company's relevant documents for other factors that may affect the company's future operating results. The Company is under no obligation to make public amendments to changes in these forward-looking statements due to specific events or reasons after the filing of these documents.

Janice Wang
Weisi investor relations service company
Tel: + 86 13811768599

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment